v3.26.1
Financial Instruments (Details 7) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Reconciliation of changes in fair value measurement, assets [abstract]    
Non-marketable shares measured at fair value through profit or loss, Beginning balance $ 69,216  
Non-marketable shares measured at fair value through profit or loss, Ending balance 83,582 $ 69,216
Financial assets    
Reconciliation of changes in fair value measurement, assets [abstract]    
Non-marketable shares measured at fair value through profit or loss, Beginning balance 69,216 53,466
Non-marketable shares measured at fair value through profit or loss, Investment 6,475 14,707
Non-marketable shares measured at fair value through profit or loss, Investment, Revaluation [1] 665 4,580
Non-marketable shares measured at fair value through profit or loss, Investment, Translation differences 7,226 (3,537)
Non-marketable shares measured at fair value through profit or loss, Ending balance 83,582 69,216
Financial liabilities    
Reconciliation of changes in fair value measurement, liabilities [abstract]    
Performance-based ("earn out') contingent consideration, Beginning balance 0 (22,941)
Performance-based ("earn out') contingent consideration, Revaluation 0 (403)
Performance-based ("earn out') contingent consideration, Repayment 0 23,344
Performance-based ("earn out') contingent consideration, Ending balance $ 0 $ 0
[1] Under financing income and expenses.